Citation Impact
Citing Papers
Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity
2004
Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response
2013 StandoutNobel
Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis
2007 Standout
A bacterium that degrades and assimilates poly(ethylene terephthalate)
2016 StandoutScience
Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47
2003 StandoutScience
Subpolar addition of new cell wall is directed by DivIVA in mycobacteria
2014 StandoutNobel
NK Cells Lyse T Regulatory Cells That Expand in Response to an Intracellular Pathogen
2008
A New Triggering Receptor Expressed on Myeloid Cells (Trem) Family Member, Trem-Like 4, Binds to Dead Cells and Is a DNAX Activation Protein 12-Linked Marker for Subsets of Mouse Macrophages and Dendritic Cells
2009 StandoutNobel
IL-10: The Master Regulator of Immunity to Infection
2008 Standout
Analysis of the genetic variation in Mycobacterium tuberculosis strains by multiple genome alignments
2008
Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB)
2000
Innate IL-17-producing cells: the sentinels of the immune system
2010 Standout
Pilon: An Integrated Tool for Comprehensive Microbial Variant Detection and Genome Assembly Improvement
2014 Standout
Innate Lymphoid Cell Interactions with Microbiota: Implications for Intestinal Health and Disease
2012
Monocyte recruitment during infection and inflammation
2011 Standout
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Regulatory T cells exert checks and balances on self tolerance and autoimmunity
2009 StandoutNobel
Elevated Pre–Antiretroviral Therapy CD39+CD8+ T Cell Frequency Is Associated With Early Mortality in Advanced Human Immunodeficiency Virus/Tuberculosis Co-infection
2017 StandoutNobel
Trends in Antimicrobial Drug Development: Implications for the Future
2004
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
2007 Standout
Interleukin-12 and the regulation of innate resistance and adaptive immunity
2003 Standout
Increased natural cytotoxicity receptor expression and relevant IL‐10 production in NK cells from chronically infected viremic HCV patients
2007
Energy transfer between fluorescent proteins using a co-expression system in Mycobacterium smegmatis
2001
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Restoration of mycobacterial antigen-induced proliferation and interferon-γ responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy
2003
Treatment of Mycobacterium avium-intracellulare complex Lung Disease With a Macrolide, Ethambutol, and Clofazimine
2003
The clinical consequences of strain diversity in Mycobacterium tuberculosis
2008
Interferon α–Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1
2012 StandoutNobel
Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review
2004 Standout
Effects of codon usage versus putative 5′-mRNA structure on the expression of Fusarium solani cutinase in the Escherichia coli cytoplasm
2002
Identification, function and structure of the mycobacterial sulfotransferase that initiates sulfolipid-1 biosynthesis
2004 StandoutNobel
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
The therapeutic approach to non-tuberculous mycobacterial infection of the lung
2010
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
2015 Standout
Functions of natural killer cells
2008 Standout
Role of the gut microbiota in immunity and inflammatory disease
2013 Standout
Metazoan MicroRNAs
2018 Standout
Does M. tuberculosis genomic diversity explain disease diversity?
2010
Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor
2011
M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells
2007 Standout
Drug repurposing: progress, challenges and recommendations
2018 Standout
Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development
2007
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Database resources for the tuberculosis community
2013
Interleukin‐10, Polymorphism inSLC11A1(formerlyNRAMP1), and Susceptibility to Tuberculosis
2002
A Riboswitch-Based Inducible Gene Expression System for Mycobacteria
2012 StandoutNobel
Tests for Latent Tuberculosis in People With ESRD: A Systematic Review
2012
Regulation of type I interferon responses
2013 Standout
The global situation of MDR-TB
2003
The microRNA miR-22 inhibits the histone deacetylase HDAC4 to promote TH17 cell–dependent emphysema
2015
Innate lymphoid cells — a proposal for uniform nomenclature
2013 Standout
InhibitingMycobacterium tuberculosiswithin and without
2016
Deletion of RD1 fromMycobacterium tuberculosisMimics Bacille Calmette‐Guérin Attenuation
2002
EspA Acts as a Critical Mediator of ESX1-Dependent Virulence in Mycobacterium tuberculosis by Affecting Bacterial Cell Wall Integrity
2010
NCBI prokaryotic genome annotation pipeline
2016 Standout
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
2013 Standout
Cellular mechanisms and physiological consequences of redox-dependent signalling
2014 Standout
Chronic Kidney Disease
2016 Standout
Comparison of a Whole-Blood Interferon γ Assay With Tuberculin Skin Testing for Detecting Latent <EMPH TYPE="ITAL">Mycobacterium tuberculosis</EMPH> Infection
2001
Sequencing technologies — the next generation
2009 Standout
5′‐Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis against free radicals during chronic infection phase in mice
2006 StandoutNobel
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Specific Detection of Tuberculosis Infection
2004
Mycobacterium tuberculosis –specific CD8 + T Cells Preferentially Recognize Heavily Infected Cells
2003
Regulation of Protein Tyrosine Phosphatase Oxidation in Cell Adhesion and Migration
2013
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling Tuberculosis in the United States
2007
NK CELL RECOGNITION
2004 Standout
Mycobacterium tuberculosis Cells Growing in Macrophages Are Filamentous and Deficient in FtsZ Rings
2006
The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46
2003
Tuberculosis Pathogenesis and Immunity
2011
Transgenic Mice Expressing Human Interleukin-10 in the Antigen-Presenting Cell Compartment Show Increased Susceptibility to Infection withMycobacterium aviumAssociated with Decreased Macrophage Effector Function and Apoptosis
2002
NK Cell-Derived IFN-γ Differentially Regulates Innate Resistance and Neutrophil Response in T Cell-Deficient Hosts Infected with Mycobacterium tuberculosis
2006
Visualization of mycobacterial membrane dynamics in live cells
2017 StandoutNobel
Interleukin-18 Regulates Both Th1 and Th2 Responses
2001
Echinococcosis: Advances in the 21st Century
2019 Standout
Functional Genomics Reveals Extended Roles of the Mycobacterium tuberculosis Stress Response Factor σ H
2009
Pattern Recognition by TREM-2: Binding of Anionic Ligands
2003
A deletion defining a common Asian lineage ofMycobacterium tuberculosisassociates with immune subversion
2006
Vimentin Expressed onMycobacterium tuberculosis-Infected Human Monocytes Is Involved in Binding to the NKp46 Receptor
2006
Osmosensory signaling in Mycobacterium tuberculosis mediated by a eukaryotic-like Ser/Thr protein kinase
2013 StandoutNobel
Role of Microglia in Central Nervous System Infections
2004
Infection of Human Macrophages and Dendritic Cells with Mycobacterium tuberculosis Induces a Differential Cytokine Gene Expression That Modulates T Cell Response
2001
THE MAGIC BULLETS AND TUBERCULOSIS DRUG TARGETS
2004
The Natural Cytotoxicity Receptor NKp46 Is Dispensable for IL-22-Mediated Innate Intestinal Immune Defense against Citrobacter rodentium
2009
Role of NK Cell-Activating Receptors and Their Ligands in the Lysis of Mononuclear Phagocytes Infected with an Intracellular Bacterium
2005
The Immune Response in Tuberculosis
2013 Standout
Dendritic cell maturation by innate lymphocytes
2005 StandoutNobel
IL-22 Produced by Human NK Cells Inhibits Growth of Mycobacterium tuberculosis by Enhancing Phagolysosomal Fusion
2009
TheMycobacterium tuberculosis19-Kilodalton Lipoprotein Inhibits Gamma Interferon-Regulated HLA-DR and FcγR1 on Human Macrophages through Toll-Like Receptor 2
2003
Depressed Interleukin-12 (IL-12), but not IL-18, Production in Response to a 30- or 32-Kilodalton Mycobacterial Antigen in Patients with Active Pulmonary Tuberculosis
2000
Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis
2012 Nobel
Genetic requirements for mycobacterial survival during infection
2003 Standout
The Inducible Nitric Oxide Synthase Locus Confers Protection against Aerogenic Challenge of Both Clinical and Laboratory Strains ofMycobacterium tuberculosisin Mice
2001
Glycine Betaine Uptake by the ProXVWZ ABC Transporter Contributes to the Ability ofMycobacterium tuberculosisTo Initiate Growth in Human Macrophages
2008
Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of β cells
2007 StandoutNobel
Identification of Concomitant Infection with Chlamydia trachomatis IncA-Negative Mutant and Wild-Type Strains by Genomic, Transcriptional, and Biological Characterizations
2008
Characterization of Murine Lung Dendritic Cells Infected withMycobacterium tuberculosis
2001
Use of a Tetracycline-Inducible System for Conditional Expression in Mycobacterium tuberculosis and Mycobacterium smegmatis
2005
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Acute Modulation of Mycobacterial Cell Envelope Biogenesis by Front‐Line Tuberculosis Drugs
2018 StandoutNobel
Phenotypical and Functional Analysis of Memory and Effector Human CD8 T Cells Specific for Mycobacterial Antigens
2006
Cell-Mediated Immune Responses in Tuberculosis
2009 Standout
Works of Buka Samten being referenced
CCR7loPD-1hi CXCR5+ CD4+ T cells are positively correlated with levels of IL-21 in active and transitional cystic echinococcosis patients
2015
The Mycobacterium tuberculosis Early Secreted Antigenic Target of 6 kDa Inhibits T Cell Interferon-γ Production through the p38 Mitogen-activated Protein Kinase Pathway
2011
Production of Interleukin‐18 in Human Tuberculosis
2000
Cytokine Production in Children with Tuberculous Infection and Disease
1999
Enhanced Capacity of a Widespread Strain ofMycobacterium tuberculosisto Grow in Human Macrophages
1999
Characterization of effector functions of human peptide-specific CD4+ T-cell clones for an intracellular pathogen
2008
The principal sigma factor sigA mediates enhanced growth of Mycobacterium tuberculosis in vivo
2004
Serum Cytokine Concentrations Do Not ParallelMycobacterium tuberculosis–Induced Cytokine Production in Patients with Tuberculosis
2003
Cytokine Profiles in Immunocompetent Persons Infected withMycobacterium aviumComplex
2001
The CD14 receptor does not mediate entry ofMycobacterium tuberculosisinto human mononuclear phagocytes
2003
IS6110 functions as a mobile, monocyte‐activated promoter in Mycobacterium tuberculosis
2004
Contribution of CD8+T Cells to Gamma Interferon Production in Human Tuberculosis
2001
NK Cells Regulate CD8+ T Cell Effector Function in Response to an Intracellular Pathogen
2004
MprAB Regulates theespAOperon in Mycobacterium tuberculosis and Modulates ESX-1 Function and Host Cytokine Response
2012
Enhanced Production of Recombinant Mycobacterium tuberculosis Antigens in Escherichia coli by Replacement of Low-Usage Codons
2000
Depressed CD40 Ligand Expression Contributes to Reduced Gamma Interferon Production in Human Tuberculosis
2000
The NKp46 Receptor Contributes to NK Cell Lysis of Mononuclear Phagocytes Infected with an Intracellular Bacterium
2002
Evidence for complex interactions of stress-associated regulons in an mprAB deletion mutant of Mycobacterium tuberculosis
2007
Early Secreted Antigenic Target of 6-kDa Protein of Mycobacterium tuberculosis Primes Dendritic Cells To Stimulate Th17 and Inhibit Th1 Immune Responses
2012
Tyrosine phosphatase PTP-MEG2 negatively regulates vascular endothelial growth factor receptor signaling and function in endothelial cells
2012
Multiple Chlamydia pneumoniae Antigens Prime CD8+ Tc1 Responses That Inhibit Intracellular Growth of This Vacuolar Pathogen
2002